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Ganglioside as an endogenous growth suppressor for glomeru- The renal glomerulus is a target for many types of injury
lar mesangial cells. caused by immunologic, hemodynamic, and metabolic
Background. Glomerular mesangial cells potentially secrete processes [1]. Numerous clinical studies have demon-many growth-modulating substances that could regulate mes-
strated that mesangial cell proliferation and/or hypercel-angial cell proliferation. To date, however, the properties of
lularity are common key features of glomerular diseasessuch factors have not been fully evaluated.
Methods. For that purpose, conditioned medium (CM) from in humans. During the last decade, researchers’ interest
mesangial cells was used for cross-feeding experiments. Cell pro- has focused on factors that induce mesangial prolifera-
liferation was evaluated by 3H-thymidine incorporation assay tion, because excessive proliferation of mesangial cellsand direct cell counting. The growth-regulatory molecule was
often accompanies increased deposition of extracellu-further characterized using biochemical techniques.
lar matrix proteins and/or glomerular scarring [2]. On theResults. Cross-feeding this CM to mesangial cells in vitro, de-
spite stimulation with platelet-derived growth factor (PDGF), other hand, for the efficient and safe resolution of glo-
effectively suppressed the cells’ synthesis of DNA in a dose- merular injury, endogenous anti-inflammatory mecha-
dependent manner. The inhibitory substance derived from mes-
nism must exist to stop the excessive growth of activatedangial cells was less than 3 kD in molecular mass, was heat
mesangial cells. The loss of the continuous control exertedstable, and was insensitive to proteinase K. After neuramini-
dase digestion, this inhibitory activity was lost. These data by endogenous growth suppressors would presumably in-
indicated that the inhibiting substance bore the typical features duce mesangial cell proliferation. Thus, understanding the
of gangliosides, which are multifunctional glycolipids that re- mechanisms that efficiently inhibit mesangial cell prolif-
side in cell membrane. Gangliosides were abundant in the CM
eration is important to the treatment of kidney disease.from mesangial cells, as detected by metabolic radiolabeling
Many endogenous factors have been cited as candidateand thin-layer chromatography (TLC). This result suggested
that mesangial cells constitutively shed gangliosides. The growth inhibitors of mesangial cell proliferation. These include
suppressive activity in the CM was blunted when mesangial transforming growth factor-1 (TGF-1) [3], heparin
cells were pretreated with the ganglioside synthesis inhibitor and heparin sulfate proteoglycan [4], nitric oxide [5],d-threo-1-phenyl-2-decanoylamino-3–morpholino-1-propanol-
prostaglandins [6], atrial natriuretic peptide [7], -inter-HCl (d-threo-PDMP; 20 mol/L) in accordance with the de-
feron [8], and the glycoprotein SPARC [9]. Endogenouscreased ganglioside content in cells. Finally, gangliosides iso-
lated from CM of mesangial cells suppressed PDGF-induced factors such as components of the extracellular matrix
DNA synthesis of mesangial cells. [10, 11] also may belong in this category.
Conclusions. These results suggest that mesangial cells con- Sialylated glycosphingolipids, also called gangliosides,stitutively shed gangliosides that then suppress the division of
are ubiquitous components of the outer leaflet of mam-these cells in an autocrine-like manner.
malian cell membranes [12]. From a series of investiga-
tions, gangliosides are now known to be involved in the
coordinated regulation of cell growth [13, 14], differenti-
ation [15, 16], morphogenesis [17, 18], and immunity
[19, 20]. Like other biological substances derived from
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cells, gangliosides also exist in normal human serum [21].glycosphingolipids, anti-inflammatory, mesangioproliferative glomeru-
lonephritis. This indicates that these molecules are constitutively
shed into the microenvironment and/or the circulationReceived for publication March 12, 2001
by certain cells. For example, tumor-specific disialogan-and in revised form May 14, 2001
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blastoma [22]. These tumor-derived gangliosides appar- 2001 by the International Society of Nephrology
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ently inhibited the proliferation of lymphocytes in the tu- serum-free DMEM/F-12 at 37C. The CM was collected
at each time point specified and then passed through amor’s microenvironment [23]. In addition, certain types
of purified gangliosides are known to inhibit mitogenesis 0.2 m filter (Millipore, Bedford, MA, USA) before
storage at 80C until use. The CM obtained after 48when added to fibroblast cells [13] or vascular smooth
muscle cells [14] in culture. These results suggest that hours of culture was generally used for cross-feeding
experiments at a concentration of 25%. The effect ofgangliosides are a significant contributor to the control
of cell growth in some settings. adding d-threo-PDMP (Matreya, Pleasant Gap, PA, USA)
[29] was studied in a similar preparation, with the excep-Gangliosides are particularly abundant in the kidney
[24]. In fact, many glycosphingolipids have been identi- tion that the cells were pretreated with 20 mol/L d-threo-
PDMP for a total of four days.fied in kidneys from several animal species [25, 26]. How-
ever, only a few reports have attempted to assess ganglio-
Cell proliferation assayside function in the kidney. Disialoganglioside GD3 was
A 3H-thymidine incorporation assay was performeddescribed as involved in the mesenchymal-epithelial in-
to measure the effect of the CM on DNA synthesis ofteraction during development of the murine kidney [18].
mesangial cells. Mesangial cells were seeded at a densityDown-regulation of the disialogangliosides O-acetyl-GD3
of 2  104 cells per well in a 24-well plate and synchro-and GD3 was reported in glomerular podocytes of rats
nized in a quiescent state by incubation for 48 hours withmanipulated to incite puromycin nephrosis [27]. Another
fresh medium containing 0.5% FBS. The medium wasreport described a possible link between the accumula-
then replaced with either serum-free medium or CM fromtion of gangliosides and glomerular hypertrophy seen in
mesangial cells. After two hours of incubation, the cellsrats undergoing experimentally induced diabetes [28].
were stimulated by adding platelet-derived growth factorThis study found that conditioned medium (CM) of
(PDGF; 10 ng/mL; Sigma Chemical) and incubated forcultured rat mesangial cells exhibits extremely powerful
20 hours. Subsequently, 2 Ci of 3H-thymidine was addedgrowth-inhibitory activity for mesangial cells. We identi-
to each well for four hours. Mesangial cells were washedfied gangliosides as a major inhibitory substance in this
three times with cold phosphate-buffered saline (PBS)CM. To our knowledge, this is the first evidence indicating
and then incubated in ice-cold 10% trichloroacetic acidthat the gangliosides are a likely candidate as the endoge-
for 20 minutes followed by ethyl-alcohol for five minutes.nous factor that controls mesangial cell proliferation.
The cells were solubilized with 0.2 mol/L NaOH, and
incorporated 3H-thymidine was counted on a liquid scin-METHODS
tillation counter. Identical cells incubated with 0.5% FBS
Cell culture without replacement of the medium were used as quies-
Rat mesangial cells were grown in cultures from isolated cent control. For the cell count, mesangial cells were
glomeruli of an adult male Sprague-Dawley rat. These seeded at a density of 4  105 cells per well in six-well
mesangial cells were identified by their typical elongated plates and synchronized in a quiescent state by incuba-
and stellar morphology, and by immunostaining for char- tion for 48 hours with fresh medium containing 0.5%
acteristic cytoskeletal filament protein (-smooth muscle FBS. The medium was then replaced with either serum-
actin) and cell-surface antigen (Thy-1). Monoclonal anti- free medium (FM) or CM from mesangial cells. After
bodies used for immunostaining had the following speci- two hours of incubation, the cells were stimulated by
ficities: mouse anti-rat Thy-1.1 monoclonal antibody PDGF (10 ng/mL). At each time point specified, the cells
(1:100 dilution, OX-7; Chemicon, Temecula, CA, USA), were harvested with trypsin and mixed with the same
mouse anti–-smooth muscle actin antibody (1:200 dilu- volume of 0.4% trypan blue solution. Only viable cells
tion, 1A4; Sigma Chemical, St. Louis, MO, USA), and were counted with a Coulter counter by light microscopy.
goat anti-mouse IgG-FITC (1:80 dilution; Santa Cruz
Biochemical analysis of CMBiotechnology, Santa Cruz, CA, USA). Mesangial cells
taken from passages 8 and 20 were used in this study. Two milliliters of CM were placed in Micron micro-
concentrators (Amicon Inc., Beverly, MA, USA) with mo-Cells were maintained in 100 mm culture plates at 37C
with 5% CO2 and fed every 48 hours with Dulbecco’s lecular mass cutoffs of 3 kD. The microconcentrator was
centrifuged at 7500 rpm for 120 minutes at 4C. Themodified Eagle’s medium (DMEM)/F-12 (NIKKEN Bio,
Kyoto, Japan) supplemented with 10% fetal bovine se- retained medium and filtrate were independently col-
lected, and the volume was restored to 2 mL. Both prepa-rum (FBS; Hyclone, Logan, UT, USA), 100 U/mL of
penicillin, and 100 g/mL of streptomycin (GIBCO rations were tested for their ability to inhibit mesangial
cell growth as described previously in this article. TheBRL, Gaithersburg, MD, USA).
fraction less than 3 kD was then evaluated for its sensitiv-
Preparation of conditioned medium ity to heat (85C for 60 min), proteinase K (50 g/mL
To prepare conditioned medium (CM), confluent mes- at 37C for 24 hours; Applied Biosystems, Foster City,
CA, USA) and neuraminidase (type V; 0.1 U/mL at 37Cangial cells grown in vitro were washed three times with
serum-free DMEM/F-12 and were incubated in 4 mL of for 24 hours; Sigma).
Tsuboi et al: Ganglioside shedding by mesangial cells1380
Metabolic radiolabeling RESULTS
A small mesangial cell-derived factor inhibitsRat mesangial cells were seeded at a density of 5 
mesangial cell proliferation106 cells per 100 mm plates and cultured for 72 hours.
To label the gangliosides, fresh medium was added con- The CM of mesangial cells was prepared as described
taining D-[1-14C]-glucosamine HCl and D-[1-14C]-galac- in the Methods section. Most of these mesangial cells
tose (Amersham Pharmacia Biotech, Amersham, UK) remained viable during this preparation period. For
to a total of 0.2 Ci/mL culture medium and incubated cross-feeding, the CM was used to pretreat quiescent
for 24 hours. The plates were washed five times with mesangial cells during a two-hour period followed by
PBS, and the cells were harvested by trypsinization to stimulation with PDGF (10 ng/mL). As shown in Fig-
be used for the ganglioside purification described below. ure 1A, a 3H-thymidine incorporation assay revealed that
To obtain gangliosides shed into culture supernatants, the CM suppressed DNA synthesis by mesangial cells
radiolabeled cells were further incubated in serum-free induced to grow by PDGF. This exclusively suppressive
medium, and the CM was collected at each time point effect of the CM was concentration dependent. Modest
specified. suppression of DNA synthesis was detected after ap-
plying 1/20 to 1/10 diluted CM, and far more substantial
Gangliosides purification suppression was observed after using CM diluted 1/4.
There was no evidence of toxicity from the CM. CellularGangliosides were purified according to the method
morphology was unchanged, and the cells did not take upof Ladish and Gillard [21]. Homogenized cell pellets
trypan blue. Furthermore, the growth-inhibitory effect ofand CM were dried by rotary evaporation. A total lipid
the CM was also confirmed by direct cell counting (Fig.fraction was obtained by extracting the starting material
1B). Mesangial cells cultured in fresh medium showedtwice with chloroform/methanol (1:1) with magnetic
substantial growth in response to PDGF. In contrast, thestring for more than 18 hours at 4C. For the extraction
growth of mesangial cells cultured in CM was stuntedof radiolabeled gangliosides, 10 g of unlabeled bovine
in response to PDGF. We then calculated the molecularbrain gangliosides (Sigma) was added as cold carrier
size of this inhibiting factor. The CM was passed throughmolecules to optimize the recovery. Gangliosides were
an ultrafiltration membrane with a 3 kD molecular sizeisolated by partitioning the dried total lipid extract in di-
cut-off, and the growth-inhibitory activity was tested byisopropyl ether, 1-butanol, and 17 mmol/L aqueous NaCl
3H-thymidine incorporation. As shown in Figure 1C, the(6:4:5, by volume). Gangliosides in the lower aqueous
fraction less than 3 kD completely inhibited DNA syn-phase were further purified by Sephadex G-25 gel filtra-
thesis by mesangial cells after PDGF stimulation. In con-tion (Amersham Pharmacia Biotech) to remove salts
trast, the fraction of more than 3 kD did not inhibitand other low molecular weight contaminants. Overall
growth, denoting the inhibitory substance was smallerrecovery of gangliosides by this method has been shown
than 3 kD. These results indicate that cultured mesangialto be 90% [21].
cells potentially release a soluble small factor that sup-
presses their proliferation, even after PDGF exposure.Gangliosides analysis
High-performance thin-layer chromatography (HPTLC) Biochemical characterization of mesangial
analysis of gangliosides was performed using precoated cell derived growth-inhibitory factor
silica gel 60 HPTLC plates (Merck, Darmstadt, Ger- The inhibitory substance in CM was characterized fur-
many), which were pre-activated by heating to 100C for ther by evaluating the 	3 kD fraction for sensitivity to
60 minutes. The plates were developed in chloroform, heat (85C for 60 min), proteinase K (50 g/mL at 37C
methanol, and 0.25% aqueous CaCl2 H2O (60:40:9, by for 24 h) and neuraminidase (0.1 U/mL at 37C for 24 h).
volume) to separate gangliosides. Gangliosides were vis- Fresh medium or 	3 kD fraction was either untreated
ualized by staining with orcinol spray reagent (Sigma). or treated with heat, proteinase K and neuraminidase,
Purified bovine gangliosides (Sigma) were spotted as and then added to mesangial cells. A 3H-thymidine incor-
migration standards. The radiolabeled gangliosides were poration assay was then performed after PDGF stimula-
revealed by exposure of the HPTLC to x-ray film (East- tion. As shown in Figure 2, the heat- and proteinase
man Kodak, Rochester, NY, USA) for 14 days at80C. K-treated samples containing the 	3 kD fraction still
possessed growth-inhibitory activity. In contrast, the in-
Statistical analysis hibitory effect was completely eliminated by neuramini-
Each experiment was performed individually at least dase digestion. To avoid direct effects to indicator cells,
three times. Comparisons were made with analysis with proteinase K and neuraminidase were heat inactivated
the Student t test. The level of a statistically significant (85C for 60 min) before cross-feeding. Since the inhibi-
tory substance in the CM was heat stable, these resultdifference was defined as P 	 0.05.
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showed that the substance was not sensitive to proteinase
K but was sensitive to neuraminidase digestion. There-
fore, the inhibitory substance was probably not a protein
but contained neuraminic acid in its active site. These
properties are consistent with those of a monomeric form
of ganglioside [30].
Detection of gangliosides in CM from
mesangial cells
To substantiate that the growth-inhibitory substance
in CM was a ganglioside, we next examined the ganglio-
side component in cultured mesangial cells. Gangliosides
were extracted from mesangial cell pellet as starting ma-
terial and were analyzed by HPTLC. The resulting pat-
tern of mesangial cell gangliosides appears in Figure
3A. In accord with a previously reported characteriza-
tion [31], monosialoganglioside GM3 seemed to be a ma-
jor ganglioside component of rat mesangial cells. More
slowly migrating bands between GM1 and GM2 and other
bands around the fraction of more complexed forms of
gangliosides also were seen. To examine whether a sub-
stantial amount of gangliosides indeed was shed into the
medium, mesangial cells were metabolically radiolabeled
with sugars, after which the gangliosides were individu-
ally extracted from either cell pellets or the CM. The
extracted gangliosides were then analyzed by HPTLC
autoradiography. A comparison of cellular gangliosides
and shed gangliosides showed that each of the major
gangliosides was clearly detectable in the culture me-
dium (Fig. 3B).
Effect of cell surface ganglioside depletion on the
growth-inhibitory activity of CM from mesangial cells
To confirm further the growth inhibitory effect of gan-
gliosides shed into culture media, pharmacological ma-
nipulation of ganglioside metabolism was performed. Mes-
angial cells were cultured for four days with an inhibitor
of ganglioside synthesis, d-threo-PDMP (20 mol/L).
After four days of culture, gangliosides were extracted
from identical amount of each cell pellet (0.5 g) either
d-threo-PDMP treated or untreated and analyzed by
HTPLC. As shown in Figure 4A, d-threo-PDMP effec-
Fig. 1. A small mesangial cell-derived factor inhibits mesangial cell pro- Mesangial cells were seeded at a density of 4  105 cells/well in six-
liferation. (A) Mesangial cells were seeded at a density of 2  104 cells/ well plates and synchronized in a quiescent state by incubation for 48
well in 24-well plates and synchronized in a quiescent state for 48 hours hours with fresh medium containing 0.5% FBS. The medium was then
by incubation with fresh medium containing 0.5% FBS. The medium replaced with fresh serum-free media (FM;) or CM ( ) at a concentra-
was then replaced with serum-free media or conditioned medium (CM) tion of 25%. After two hours of incubation, the cells were stimulated
from mesangial cells (MC-CM). After two hours of incubation, the cells by PDGF (10 ng/mL). At each time point, the cells were harvested
were stimulated by PDGF (10 ng/mL) for 20 hours. Subsequently, 2 with trypsin and counted with a Coulter counter. *P 	 0.05 vs. FM.
Ci of 3H-thymidine was added to each well and incubated for four (C ) CM was passed through an ultrafiltration membrane with a 3 kD
hours. Total cell-associated 3H-thymidine counts were determined after molecular size cut-off. Each fraction of less or more than 3 kD was
washing and harvesting the cells. The cells incubated with 0.5% FBS tested for growth inhibitory activity by the 3H–thymidine incorporation
without replacement of the medium were used as quiescent control. assay described previously in this article. ***P 	 0.001 vs. FM; ##P 	
*P 	 0.05; **P 	 0.01; ***P 	 0.001 vs. fresh media, respectively. (B) 0.01; ###P 	 vs. unfractioned, respectively.
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Fig. 2. Biochemical characterization of the mes-
angial cell-derived growth-inhibitory factor. The
growth-inhibitory molecule smaller than 3 kD
was then evaluated for its sensitivity to heat
(85C for 60 min), proteinase K (50 g/mL at
37C for 24 h), and neuraminidase (0.1 U/mL
at 37C for 24 h). After treatment, each CM
was subjected to a 3H-thymidine incorporation
assay, as described in Figure 1. To avoid direct
toxic effects to indicator cells, proteinase K and
neuraminidase were heat inactivated (85C for
60 min) before cross-feeding. ***P 	 0.001 vs.
fresh media; ###P 	 0.001 vs. nontreated of
CM 	3 kD fraction, respectively.
tively depleted the cellular content of gangliosides. The pressed PDGF-induced DNA synthesis by mesangial cells.
This inhibitory effect did not result from contaminationCM of d-threo-PDMP–treated mesangial cells was then
tested for growth inhibition. After treatment with the by toxic agents during the process of extracting ganglio-
inhibitor, the cells were washed and resuspended in fresh sides, because the negative control, which was processed
medium without the inhibitor. As shown in Figure 4B, with the same extraction steps used for CM, completely
a 3H-thymidine incorporation assay revealed that the failed to inhibit growth.
inhibition of growth was significantly attenuated by treat-
ment with d-threo-PDMP. These results are consistent
DISCUSSIONwith the notion that gangliosides derived from mesangial
In this study, conditioned medium was prepared fromcells were responsible for the inhibition of growth. A
cultured rat mesangial cells and demonstrated its extremelysimilar effect was obtained when these CM, both PDMP-
potent ability to inhibit the growth of mesangial cell intreated and untreated, were passed through an ultrafil-
separate cultures. The inhibitory substance derived fromtration membrane with a 3 kD molecular size cut-off
mesangial cells was less than 3 kD and was sensitive to(data not shown). These results further support the idea
neuraminidase digestion. These were typical characteris-that attenuated growth inhibitory effect is due to the
tic features of gangliosides. Despite the many inhibitorsdecreased shedding of gangliosides in which the molecu-
of mesangial cell proliferation proposed to date, nonelar size is less than 3 kD.
of these molecules except nitric oxide was smaller than
Gangliosides isolated from CM of mesangial cells 3 kD, and none was sensitive to neuraminidase digestion.
reproduce the growth-inhibitory effect Both qualities were necessary to inhibit mesangial cell
proliferation in our experiments. Furthermore, we dem-We next examined whether gangliosides isolated from
CM of mesangial cells could reproduce the growth inhibi- onstrated a substantial amount of gangliosides in the CM
used here to produce a growth inhibitory effect for mes-tory effect. Gangliosides were extracted from the CM,
and the volume was restored by adding fresh medium. angial cells. In addition, the purified gangliosides (GM1,
GM2, GM3, and GD3; 10 to 50 mol/L) effectively sup-Isolated gangliosides were then tested for growth inhibi-
tory activity by 3H-thymidine incorporation. As Figure 5 pressed PDGF-induced DNA synthesis of mesangial cells
(data not shown). These results strongly suggest that gan-illustrates, gangliosides derived from the CM greatly sup-
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Fig. 4. Effect of cell surface ganglioside depletion on growth-inhibitory
activity of CM from mesangial cells. (A) Mesangial cells were cultured
for four days in an inhibitor of ganglioside synthesis, d-threo-PDMP
(20 mol/L). After four days of culture, gangliosides were extracted
from each cell pellets by using the same amounts (0.5 g) from either
d-threo-PDMP–treated or -untreated preparations (Methods section)
and analyzed by HTPLC. Gangliosides were visualized by staining with
orcinol spray. Purified bovine gangliosides were spotted as migration
standards. (B) After treatment of the inhibitor, the cells were washed
and resuspended in fresh medium without the inhibitor. CM of d-threo-
Fig. 3. Detection of gangliosides in CM from mesangial cells. (A) High- PDMP-treated mesangial cells and that of untreated cells were tested
performance thin layer chromatography (HPTLC) analysis of mesangial for growth-inhibitory activity by a 3H-thymidine incorporation assay as
cell gangliosides. Gangliosides were extracted from mesangial cell pel- described in Figure 1. CM collected at 24 hours was used in this experi-
lets as the starting material (Methods section). The plates were devel- ment at a concentration of 50%. **P 	 0.01 vs. untreated cells.
oped in chloroform, methanol, and 0.25% aqueous CaCl2 H2O (60:40:9,
by volume) to separate gangliosides. Gangliosides were then visualized
by staining with orcinol spray. Purified bovine gangliosides were spotted
gliosides were a significant contributor to the suppressionas migration standards. (B) Rat mesangial cells were metabolically
radiolabeled with D-[1-14C]-glucosamine HCl and D-[1-14C]-galactose of growth by CM. To our knowledge, this is the first
and gangliosides were analyzed by HPTLC autoradiography. Radio- evidence indicating that the gangliosides are the endoge-labeled gangliosides, isolated from the cell pellet (Cell) and CM (Shed)
nous factor that controls mesangial cell proliferation,were spotted in each lane. After each HPTLC plate was developed, it
was exposed to x-ray film for two weeks. Each lane contains 2000 dpm which is a pivotal pathophysiological process in many
14C-labeled gangliosides. glomerular diseases.
Gangliosides are structurally diverse acidic glycosphin-
golipids found in the plasma membrane of nearly all
eukaryotic cells [12]. Since certain tumor cells exhibit an
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attempting to study whether systemic injection of CM
and/or isolated gangliosides can inhibit MC growth in
experimental models of glomerulonephritis.
Recently, Groggel and Hughes reported that CM of
primary glomerular cultures contained a factor that could
inhibit mesangial cell proliferation [39]. The factor was
shown to be smaller than 3 kD. That outcome is fully
consistent with our results showing that cultured mesan-
gial cells secrete a growth inhibitor of mesangial cells
whose mass is less than 3 kD. This inhibitor exhibited
the characteristic features of a ganglioside in our experi-
ments. Notably, the data by Groggel and Hughes showed
that the growth-inhibitory effects of CM from isolated
glomeruli were significantly attenuated when rats were
subjected to puromycin aminonucleotide nephrosis, a
model of injury for glomerular podocytes. Their results
indicate that growth-suppressive gangliosides also may
be shed by glomerular podocytes. Elsewhere, disialo-
gangliosides O-acetyl-GD3 and GD3 were selectively
down-regulated in glomerular podocytes of rats similarly
subjected to an experimental nephritic syndrome [27].
The mechanisms by which gangliosides inhibit mesan-Fig. 5. Gangliosides isolated from CM of mesangial cells reproduce
the growth-inhibitory effect. Gangliosides were extracted from 8 mL of gial cell proliferation are not defined. However, certain
CM as described in the Methods section, and the volume was restored gangliosides inhibited the PDGF-induced tyrosine auto-
to 8 mL by adding fresh medium. Isolated gangliosides were then tested
phosphorylation of PDGF receptor in NIH 3T3 fibro-for growth-inhibitory activity with a 3H-thymidine incorporation assay
as described in the legend for Figure 1. Media with the same steps blasts and vascular smooth muscle cells [13, 14]. Our pre-
used to extract gangliosides were the negative controls; the starting liminary data showed that CM from mesangial cells also
material was 8 mL of fresh media. ***P 	 0.001 vs. fresh media or
inhibited 3H-thymidine incorporation into mesangial cellsnegative control.
induced by basic fibroblast growth factor (bFGF), an-
other important growth factor for mesangial cells [40].abnormality in the expression of gangliosides, these fac-
On the other hand, gangliosides are capable of incorpo-tors may participate in the pathogenesis of malignant
ration into cellular membranes, interaction with mole-transformation [32, 33]. Additionally, tumor cell gangli-
cules associated with signal transduction pathways, andosides are often shed into microenvironment and have
alteration of cellular functions [41, 42]. Moreover, a re-been associated with tumor-specific immune escape [34,
cent report showed that free gangliosides directly inter-35]. However, the role of ganglioside shedding in physio-
acted with bFGF peptides [43]. Gangliosides may addi-logical situations or nonmalignant diseases is not well
tionally inhibit mesangial cell proliferation by interventionunderstood. In glomerulonephritis, the damage to tissue
in multiple mechanisms. Once the characterization ofmay be destined to either worsen or heal depending on
gangliosides derived from mesangial cells is more pre-the balance between local offense factors and defense
cise, the mechanisms by which they suppress growth willmachinery [36]. Accordingly, mesangial cell-derived gan-
be amenable to more detailed study.gliosides may facilitate the resolution of glomerular in-
In summary, we have identified gangliosides as a po-jury by inhibiting excessive proliferation and activation
tential endogenous factor that suppresses mesangial cellof mesangial cells. An important fact of the culture condi-
tion we used here was that mesangial cells exhibited proliferation. This indicates that gangliosides can be a sig-
the phenotype of activated cells in vivo and, therefore, nificant modulator of cellular responses in glomerular dis-
represented a disease-like state [37, 38]. It is reasonable eases such as mesangioproliferative glomerulonephritis.
to speculate that defensive gangliosides are conditionally
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